Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

Retatrutide / Cagrilintide Blend Dosage & Reconstitution

Retatrutide 5 mg + Cagrilintide 5 mg. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.

1Set Up Your Mix

10 mg/mL · 10000 mcg/mL

Your Answer — Retatrutide / Cagrilintide Blend

10 mg in 1 mL
12Draw To This Line
0.12That's This Many mL
8Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 12
10 mg ÷ 1 mL = 10 mg/mL  →  1.2 mg ÷ 10 mg/mL = 0.12 mL  →  × 100 = 12 units
Looks good. Draw to 12 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 8 doses.
When to dose
Time of dayNo particular time of day has been established.
FoodNo fasting requirement has been established.

The studies behind this compound did not test timing or food state as variables, so we are not going to invent a rule. Pick a time you can keep to consistently.

2Week-By-Week Plan — Retatrutide / Cagrilintide Blend

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Weeks 1–4 1.2 mg once weekly 0.12 mL 12 u 4 4.8 mg
Weeks 5–8 2.4 mg once weekly 0.24 mL 24 u 4 9.6 mg
Week 9 onward
per 4 weeks from here on
4.8 mg once weekly 0.48 mL 48 u 4 19.2 mg
Time until the top dose
8 weeks
Peptide used getting there
14.4 mg
Vials you'll need
2 × 10 mg
Once you're at the top dose
19.2 mg / 4 wk · 1.92 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — Retatrutide / Cagrilintide Blend

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Low reported 1.2 mg once weekly · 0.6 mg of each compound 0.12 mL 12 u 8 doses
Standard 2.4 mg once weekly · 1.2 mg of each compound 0.24 mL 24 u 4 doses
Upper reported 4.8 mg once weekly · 2.4 mg of each compound 0.48 mL 48 u 2 doses
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About Retatrutide / Cagrilintide Blend

Multi-Compound Blends
Also known as
Retatrutide 5 mg + Cagrilintide 5 mg
Class
Multi-Compound Blends
Route
Subcutaneous
Half-life
Mixed (~6–8 days)
Evidence tier
Preclinical

Equal parts of a triple incretin agonist and an amylin analogue — 5 mg of each in a 10 mg vial, once weekly. The thing to understand before dosing it: the two components were trialled on very different scales. Retatrutide ran up to 12 mg weekly, cagrilintide only to 2.4 mg. Because a 1:1 blend moves both together, cagrilintide hits its ceiling at 4.8 mg total — and at that point retatrutide is still only at 2.4 mg, nowhere near its higher arms. Cagrilintide is what caps this blend, and pushing past it takes the amylin component beyond anything that has been tested.

Buy Retatrutide / Cagrilintide Blend

Common Questions — Retatrutide / Cagrilintide Blend

How much bacteriostatic water do I add to a 10 mg vial of Retatrutide / Cagrilintide Blend?

Adding 1 mL of bacteriostatic water to a 10 mg vial gives 10 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.

What dose of Retatrutide / Cagrilintide Blend is used in research?

Published and reported figures for Retatrutide / Cagrilintide Blend run from 1.2 mg to 4.8 mg, typically once weekly (0.6 mg each).2 mg to 4.8 mg, typically once weekly (0.6 mg each). This site lists each figure with the source it came from rather than giving a single recommended number.

How many units on the syringe is a 1.2 mg dose of Retatrutide / Cagrilintide Blend?

At 10 mg/mL, a 1.2 mg dose is 12 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 8 doses.

How strong is the evidence behind these Retatrutide / Cagrilintide Blend doses?

Retatrutide / Cagrilintide Blend is graded preclinical. Laboratory and animal data only. No human dosing trials have been published. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.

Why an incretin is paired with an amylin analogue

10 mg vial
What is in the vial
  • Retatrutide 5 mg
  • Cagrilintide 5 mg

Two different appetite pathways. Retatrutide is a triple GIP/GLP-1/glucagon agonist; cagrilintide is a long-acting amylin analogue. Amylin and incretin signalling are separate systems, and combining them is an active area of clinical development — the cagrilintide plus semaglutide combination has been trialled in humans.

That said, this specific pairing has not. And retatrutide itself is not approved anywhere, so a blend containing it inherits every caveat on the retatrutide page.

The ratio matters. An even 5 mg + 5 mg split, so a 1.2 mg dose is 0.6 mg of each.

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials
See component entries: Retatrutide, Cagrilintide No blend-specific literature exists
Nothing has tested this pairing. The tiers above are capped by cagrilintide, whose 2.4 mg ceiling is reached well before retatrutide approaches its own upper arms.
Find on PubMed ↗
Cagrilintide plus semaglutide combination trials (CagriSema) Frías JP, et al. The Lancet, 2023
The closest tested analogue — an amylin analogue combined with an incretin agonist, though with semaglutide rather than retatrutide.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Other multi-compound blends peptides

Compounds in the same class, or browse the full catalogue.

BPC-157 / KPV Blend

An equal-parts repair and anti-inflammatory pairing — 10 mg of each in a 20 mg vial, so every dose splits evenly down the middle a…

CJC-1295 / Ipamorelin Blend

A GHRH analogue paired with a selective ghrelin receptor agonist — the pairing rationale is that the two receptors act synergistic…

All 72 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.

Need this on one page to print, screenshot or send?

Make a dose card →